Saturday 18 May, 2024 07:21 PM
Site map | Locate Us | Login
   Go Digit General Insurance IPO ends with better subscription    Kirloskar Ferrous Q4 PAT drops 81% YoY to Rs 18 cr    ZEEL reports turnaround Q4 numbers    NHPC Q4 PAT slides 18% to Rs 610 cr    Nestle India ends higher after public shareholders reject royalty hike proposal to Swiss parent    Sobha Q4 PAT drops 85% YoY to Rs 7 cr    Kirloskar Ferrous Industries Ltd leads losers in 'A' group    Vindhya Telelinks Ltd leads losers in 'B' group    Volumes soar at MTAR Technologies Ltd counter    Godrej Inds slides on reporting net loss of Rs 312 cr in Q4    Granules India Ltd gains for third consecutive session    Glenmark Pharmaceuticals Ltd up for third straight session    Aurobindo Pharma Ltd spurts 3.21%    National Aluminium Company Ltd gains for third straight session    Zee Entertainment Enterprises Ltd spurts 4.37% 
Saravan Stocks
       
Company News
Nestle India Ltd
Nestle India and Dr Reddy's to form JV focused on nutritional health solutions
Apr 25,2024   Hrs IST

Nestlé India and Dr. Reddy's Laboratories announced that they have entered into a definitive agreement to form a joint venture to bring innovative nutraceutical brands to consumers in India and other agreed territories.

The partnership will bring together the well-known global range of nutritional health solutions as well as vitamin, minerals, herbals and supplements of Nestlé Health Science (NHSc) with the strong and established commercial strengths of Dr. Reddy's in India.

The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios in categories such as metabolic, hospital nutrition, general wellness , women's health and child nutrition for consumers across India. The JV Company will be headquartered in Hyderabad. The JV Company will leverage the capabilities as well as services of the Nestlé Group and Dr. Reddy's.

Select brands will be licensed by the JV Partners to the JV company. The Nestlé Group will license brands such as Nature's Bounty, Osteo Bi-Flex, Ester-C, Resource High Protein, Optifast, Resource Diabetic, Peptamen, Resource Renal and Resource Dialysis. Dr. Reddy's will license brands such as Rebalanz, Celevida, Antoxid, Kidrich-D3, Becozinc in the nutrition, and OTC segments. The JV Company is expected to become operational in Q2 of FY'25.

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 32675512
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd